We are live on
!
Find out more
HC
Henshaw Capital Portfolio holdings
AUM
$2.7B
1-Year Est. Return
29.67%
This Fund
S&P 500
This Quarter
Est. Return
+13.94%
1 Year Est. Return
+29.67%
3 Year Est. Return
+102.72%
5 Year Est. Return
+136.36%
10 Year Est. Return
+453.01%
AUM
$1.33B
AUM Growth
+$36.1M
(+2.8%)
Cap. Flow
-$115M
Cap. Flow
% of AUM
-8.68%
Top 10 Holdings %
Top 10 Hldgs %
37.57%
Holding
362
New
48
Increased
85
Reduced
71
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$3.78M |
| 2 |
Viatris
VTRS
|
+$1.26M |
| 3 |
WEX
WEX
|
+$553K |
| 4 |
Unilever
UL
|
+$539K |
| 5 |
CACI
CACI
|
+$527K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$45.3M |
| 2 |
Apple
AAPL
|
+$33.7M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$8.46M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$8.41M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$7.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.03% |
| 2 | Industrials | 15.85% |
| 3 | Consumer Discretionary | 11.78% |
| 4 | Financials | 11.67% |
| 5 | Healthcare | 11.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
AT&T
T
$159B
| – | – |
-19,728
| Closed | -$425K |
|
352
Takeda Pharmaceutical
TAK
$54.6B
| – | – |
-30,391
| Closed | -$542K |
|
353
Toronto Dominion Bank
TD
$198B
| – | – |
-4,599
| Closed | -$213K |
|
354
XP
XP
$8.81B
| – | – |
-6,195
| Closed | -$258K |
|
355
Zoetis
ZTS
$32.4B
| – | – |
-1,728
| Closed | -$286K |
|
|
HOLI
356
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| – | – |
-11,412
| Closed | -$126K |
|
|
TMX
357
DELISTED
Terminix Global Holdings, Inc.
TMX
| – | – |
-54,469
| Closed | -$2.17M |
|
|
TUFN
358
DELISTED
Tufin Software Technologies Ltd.
TUFN
| – | – |
-11,390
| Closed | -$94K |
|
|
VAR
359
DELISTED
Varian Medical Systems, Inc.
VAR
| – | – |
-5,903
| Closed | -$1.02M |
|
|
MYOK
360
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| – | – |
-1,698
| Closed | -$231K |
|
|
CHL
361
DELISTED
China Mobile Limited
CHL
| – | – |
-15,558
| Closed | -$500K |
|
|
UN
362
DELISTED
Unilever NV New York Registry Shares
UN
| – | – |
-9,665
| Closed | -$584K |
|
Similar funds
CI
LP
HCM
SCM
BCM
NB
WGI
MMEA
Henshaw Capital's Q4 2020 Portfolio in Review
As of Q4 2020, Henshaw Capital held 362 positions worth $1.33B, up 2.8% from $1.29B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Henshaw Capital withdrew a net $115M in Q4 2020, closing 21 positions and reducing 71 holdings. Its most notable exit was WisdomTree Japan Hedged Equity Fund, an estimated $6.37M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Henshaw Capital opened a new position in Viatris worth $1.45M.
- Henshaw Capital's largest Q4 2020 buy was Viatris: 77,330 shares worth $1.45M.
- Henshaw Capital added most to Amgen in Q4 2020, an estimated $3.78M increase.
- Henshaw Capital's biggest Q4 2020 reduction was Meta Platforms (Facebook), cutting an estimated $45.3M.
- Henshaw Capital fully exited WisdomTree Japan Hedged Equity Fund in Q4 2020, selling an estimated $6.37M.
- Henshaw Capital's ten largest holdings make up 38% of its $1.33B portfolio in Q4 2020.
- Henshaw Capital opened 48 new positions and closed 21 in Q4 2020.
- Henshaw Capital's portfolio value rose 2.8% quarter-over-quarter to $1.33B.
Based on Henshaw Capital's 13F filing for Q4 2020, filed 28 May 2026.